Introduction
Materials and methods
Study population
Selection of cases and inclusion criteria
Surgical procedures
Microbiological data
Antibiotic therapy
Data collection
Statistical analysis
Results
Comparison between patients without and with persistent abdominal sepsis
Without persistent peritonitis
|
Persistent peritonitis
|
P
| |
---|---|---|---|
n = 122
|
n = 98
| ||
Male gender, n (%) | 59 (48) | 58 (59) | 0.10 |
Age, mean ± SD | 62 ± 18 | 62 ± 14 | 0.99 |
Comorbidities | |||
Cancer, n (%) | 51 (42) | 35 (36) | 0.35 |
Diabetes, n (%) | 21 (17) | 10 (10) | 0.17 |
Immunosuppression, n (%) | 17 (14) | 9 (9) | 0.29 |
SAPS II score, mean ± SD | 49 ± 23 | 50 ± 16 | 0.85 |
SOFA score, mean ± SD | 6.8 ± 3.9 | 8.2 ± 3.2 | 0.01 |
Haemodynamic failure1, n (%) | 49 (40) | 59 (60) | 0.003 |
Respiratory failure1, n (%) | 32 (26) | 36 (37) | 0.09 |
Renal failure1, n (%) | 16 (13) | 22 (22) | 0.07 |
Initial procedure leading to postoperative peritonitis | |||
Emergency surgery, n (%) | 43 (35) | 47 (48) | 0.056 |
Elective surgery, n (%) | 79 (65) | 51 (52) | - |
Characteristics of the initial surgical procedure | |||
Gastroduodenal surgery, n (%) | 32 (26) | 31 (32) | 0.37 |
Colonic surgery, n (%) | 48 (39) | 45 (46) | 0.32 |
Small bowel surgery, n (%) | 20 (16) | 19 (19) | 0.59 |
Other type of surgery, n (%) | 22 (18) | 11 (11) | 0.18 |
Aetiology of postoperative peritonitis | |||
Bowel perforation, n (%) | 42 (34) | 48 (49) | 0.029 |
Anastomotic leakage, n (%) | 42 (34) | 30 (30) | 0.54 |
Purulent collection, n (%) | 17 (14) | 20 (20) | 0.21 |
Other causes, n (%) | 21 (18) | 19 (19) | 0.72 |
Primary site of infection above transverse mesocolon, n (%) | 30 (25) | 32 (33) | 0.18 |
Colonic site of infection, n (%) | 40 (33) | 35 (36) | 0.65 |
Small bowel site of infection, n (%) | 49 (41) | 32 (33) | 0.25 |
Gastric site of infection, n (%) | 26 (21) | 25 (26) | 0.46 |
Creation of ostomy, n (%) | 62 (53) | 54 (47) | 0.52 |
Adequacy of empirical antibiotic therapy, n (%) | 79 (65) | 63 (64) | 0.94 |
Use of combination of antibiotic therapy, n (%) | 88 (72) | 84 (86) | 0.02 |
Use of carbapenems, n (%) | 24 (20) | 29 (30) | 0.09 |
Use of piperacillin/tazobactam, n (%) | 84 (69) | 62 (63) | 0.38 |
Use of vancomycin, n (%) | 43 (35) | 50 (51) | 0.02 |
Use of aminoglycosides, n (%) | 50 (41) | 53 (54) | 0.053 |
Use of empirical antifungal therapy, n (%) | 30 (25) | 43 (44) | 0.002 |
Microorganisms
|
Without persistent peritonitis
|
Persistent peritonitis
|
P
|
---|---|---|---|
Aerobes, n (%) | 292 (78) | 209 (73) | 0.17 |
Gram-positive bacteria, n (%) | 141 (38) | 94 (33) | 0.21 |
Enterococci, n (%) | 71 (19) | 45 (16) | 0.29 |
E. faecalis, n (%)
| 40 (11) | 21 (7) | 0.17 |
E. faecium, n (%) | 16 (4) | 12 (4) | 1.0 |
Streptococci, n (%) | 32 (9) | 34 (12) | 0.15 |
Staphylococci, n (%) | 37 (10) | 13 (5) | 0.011 |
Staphylococcus aureus, n (%) | 12 (3) | 3 (1) | 0.11 |
Coagulase-negative staphylococci, n (%) | 25 (7) | 10 (4) | 0.08 |
Gram-negative bacteria, n (%) | 151 (40) | 115 (40) | 0.98 |
Enterobacteriaceae, n (%) | 122 (32) | 95 (33) | 0.83 |
Escherichia coli, n (%) | 56 (15) | 48 (17) | 0.50 |
Enterobacter spp, n (%) | 20 (5) | 12 (4) | 0.58 |
Klebsiella spp, n (%) | 20 (5) | 11 (4) | 0.45 |
Morganella spp, n (%) | 10 (3) | 10 (4) | 0.64 |
Proteus spp, n (%) | 11 (3) | 5 (2) | 0.44 |
Non-fermenting Gram-negative bacilli, n (%) | 24 (6) | 12 (4) | 0.23 |
Pseudomonas aeruginosa, n (%) | 22 (6) | 12 (4) | 0.37 |
Anaerobes, n (%) | 48 (13) | 34 (12) | 0.73 |
Bacteroides spp, n (%) | 31 (8) | 28 (10) | 0.49 |
Fungi, n (%) | 36 (10) | 43 (15) | 0.03 |
Candida albicans, n (%) | 23 (6) | 34 (12) | 0.011 |
Candida non-albicans, n (%) | 13 (3) | 8 (3) | 0.66 |
Total number of microorganisms, n | 376 | 286 | |
Total number of MDR bacteria, n (%) | 49 (13) | 35 (14) | 0.76 |
Characteristics of patients with persistent sepsis at the time of additional reoperation
First repeat laparotomy
|
Second repeat laparotomy
|
Third repeat laparotomy
|
P
| |
---|---|---|---|---|
n = 98
|
n = 54
|
n = 21
| ||
Time since previous surgery, days, mean ± SD | 5 ± 5 | 6 ± 4 | 6 ± 5 | 0.32 |
Reasons for reoperation | ||||
Sepsis, n (%) | 23 (23) | 17 (32) | 3 (16) | 0.27 |
Septic shock, n (%) | 59 (60) | 28 (55) | 12 (63) | 0.61 |
Other reasons, n (%) | 16 (16) | 9 (17) | 6 (29) | 0.40 |
Intraoperative diagnosis, n (%) | ||||
Anastomotic leakage, n (%) | 25 (26) | 9 (17) | 4 (21) | 0.43 |
Perforation or ischaemia, n (%) | 17 (17) | 14 (26) | 4 (21) | 0.44 |
Purulent collection, n (%) | 27 (28) | 15 (28) | 5 (26) | 0.93 |
Other causes, n (%) | 8 (7) | 10 (18) | 2 (10) | 0.15 |
No cause, n (%) | 21 (21) | 6 (11) | 6 (32) | 0.15 |
Clinical characteristics at the time of reoperation | ||||
Temperature, °C, mean ± SD | 38.2 ± 1.2 | 38.1 ± 1.4 | 38.0 ± 1.5 | 0.53 |
WBCs, 109/L, mean ± SD | 19.5 ± 11.2 | 20.7 ± 10.6 | 21.6 ± 10.5 | 0.65 |
Creatinine (μmol/L) | 159 ± 121 | 180 ± 129 | 202 ± 153 | 0.30 |
SOFA score, mean ± SD | 7 ± 4 | 8 ± 4 | 9 ± 3 | 0.33 |
≥2 organ dysfunctions, n (%) | 45 (46) | 27 (50) | 11 (52) | 0.81 |
Haemodynamic failure1, n (%) | 62 (63) | 31 (57) | 14 (67) | 0.69 |
Respiratory failure1, n (%) | 38 (39) | 22 (41) | 5 (24) | 0.37 |
Renal failure1, n (%) | 25 (26) | 18 (33) | 4 (21) | 0.39 |
Index operation for postoperative peritonitis
|
First reoperation
|
Second reoperation
|
Third reoperation
|
---|---|---|---|
n = 98
|
n = 98
|
n = 54
|
n = 21
|
Bowel perforations n = 48 | Bowel perforations n = 17 | Bowel perforations n =14 | Bowel perforations n =4 |
12 bowel perforations at S0 | 3 bowel perforations at R1 | 1 purulent collection at R2 | |
5 suture leakages at S0 | 5 suture leakages at R1 | 2 suture leakages at R2 | |
2 purulent collections at S0 | 1 purulent collection at R1 | 1 other cause at R2 | |
4 other causes at S0 | 2 other causes at R1 | ||
3 no causes at R1 | |||
Suture leakages n = 30 | Suture leakages n = 25 | Suture leakages n = 9 | Suture leakages n = 4 |
10 bowel perforations at S0 | 1 bowel perforation at R1 | 2 bowel perforations at R2 | |
11 suture leakages at S0 | 4 suture leakages at R1 | 2 suture leakages at R2 | |
5 purulent collections at S0 | 1 purulent collection at R1 | ||
4 other causes at S0 | 3 no causes at R1 | ||
Purulent collections n = 20 | Purulent collections n = 27 | Purulent collections n = 15 | Purulent collections n = 5 |
13 bowel perforations at S0 | 2 bowel perforations at R1 | 2 bowel perforations at R2 | |
9 suture leakages at S0 | 4 suture leakages at R1 | 1 suture leakages at R2 | |
6 purulent collections at S0 | 4 purulent collections at R1 | 1 purulent collection at R2 | |
4 other causes at S0 | 2 other causes at R1 | 1 other cause at R2 | |
3 no causes at R1 | |||
Other causes n = 19 | Other causes n = 8 | Other causes n = 10 | Other causes n = 2 |
3 suture leakages at S0 | 3 bowel perforations at R1 | 1 suture leakage at R2 | |
3 perforations at S0 | 3 suture leakages at R1 | 1 purulent collection at R2 | |
3 purulent collections at S0 | 2 purulent collections at R1 | ||
2 other causes at S0 | 1 other cause at R1 | ||
No causes n = 21 | No causes n = 6 | No causes n = 6 | |
13 bowel perforations at S0 | 3 purulent collections at R1 | 2 suture leakages at R2 | |
2 suture leakages at S0 | 2 suture leakages at R1 | 2 purulent collections at R2 | |
4 purulent collections at S0 | 1 no cause at R1 | 2 other causes at R2 | |
5 other causes at S0 |
Microbiological examinations in patients with persistent sepsis at the time of reoperation
Microorganisms
|
Index surgery
|
First reoperation
|
Second reoperation
|
Third reoperation
|
---|---|---|---|---|
Aerobes, n (%) | 209 (73) | 157 (71) | 89 (75) | 33 (75) |
Gram-positive bacteria, n (%) | 94 (33) | 69 (31) | 36 (31) | 12 (27) |
Enterococci, n (%) | 45 (16) | 38 (17) | 18 (15) | 4 (9) |
E. faecalis, n (%)
| 21 (7) | 11 (5) | 8 (7) | 0 |
E. faecium, n (%) | 12 (4) | 15 (7) | 7 (6) | 4 (9) |
Streptococci, n (%) | 34 (12) | 7 (3)†
| 1 (1)†
| 0* |
Staphylococci, n (%) | 13 (5) | 22 (10)* | 16 (14)†
| 7 (16)†
|
Staphylococcus aureus, n (%) | 3 (1) | 1 (1) | 1 (1) | 1 (2) |
Coagulase-negative staphylococci, n (%) | 10 (4) | 21 (9) | 15 (13) | 6 (14) |
Gram-negative bacteria, n (%) | 115 (40) | 88 (40) | 53 (45) | 21 (48) |
Enterobacteriaceae, n (%) | 95 (33) | 70 (32) | 35 (30) | 15 (34) |
Escherichia coli, n (%) | 48 (17) | 35 (16) | 18 (15) | 4 (9) |
Enterobacter spp, n (%) | 12 (4) | 10 (5) | 7 (6) | 4 (9) |
Klebsiella spp, n (%) | 11 (4) | 9 (4) | 4 (3) | 2 (5) |
Morganella spp, n (%) | 10 (4) | 6 (3) | 2 (2) | 1 (2) |
Proteus spp, n (%) | 5 (2) | 2 (1) | 2 (2) | 1 (2) |
Other Enterobacteriaceae, n (%) | 9 (3) | 8 (4) | 2 (2) | 3 (7) |
Non-fermenting Gram-negative bacilli, n (%) | 12 (4) | 18 (8) | 16 (14)†
| 5 (11) |
Pseudomonas aeruginosa, n (%) | 12 (4) | 14 (6) | 11 (9) | 5 (11) |
Acinetobacter spp, n (%) | 0 | 4 (2) | 3 (3) | 0 |
Anaerobes, n (%) | 34 (12) | 8 (4)†
| 2 (2)†
| 1 (2) |
Bacteroides spp, n (%) | 28 (10) | 5 (2)†
| 2 (2)†
| 1 (2) |
Fungi, n (%) | 43 (15) | 57 (26)†
| 27 (23) | 10 (23) |
Candida albicans, n (%) | 34 (12) | 41 (18)* | 22 (19) | 8 (18) |
Candida non-albicans, n (%) | 8 (3) | 14 (6) | 4 (3) | 2 (5) |
Total number of microorganisms, n | 286 | 222 | 118 | 44 |
Emergence of microorganisms
Adequacy of antibiotic therapy and duration of therapy
No persistent peritonitis
|
Persistent peritonitis
| ||||
---|---|---|---|---|---|
Index surgery
|
First reoperation
|
Second reoperation
|
Third reoperation
| ||
Patients with inadequate therapy, n (%) | 43 (35) | 35 (36) | 32 (33) | 16 (30) | 7 (33) |
One organism not targeted, n (%) | 29 (24) | 10 (10) | 26 (27) | 11 (20) | 6 (29) |
Staphylococci, n (%)* | 11 (3) | 13 (5) | 13 (6) | 6 (5) | 3 (7) |
Methicillin-resistant coagulase-negative staphylocci, n (%)* | 7 (2) | 11 (4) | 12 (5) | 5 (4) | 3 (7) |
Enterococci, n (%)* | 14 (4) | 6 (2) | 7 (3) | - | - |
Enterococcus faecium, n (%)* | 12 (3) | 5 (2) | 4 (2) | ||
Enterobacteriaceae, n (%)* | 13 (3) | 9 (3) | - | 3 (3) | 2 (5) |
Non-fermenting Gram-negative bacilli, n (%)* | 2 (1) | 4 (1) | 6 (3) | 7 (6) | - |
Candida species, n (%)* | 18 (5) | 13 (5) | 12 (5) | 5 (4) | 2 (5) |
Candida albicans, n (%)* | 14 (4) | 7 (2) | 9 (4) | 3 (3) | 2 (5) |
Risk factors for emergence of bacteria
Variable
|
Univariate analysis
|
Multivariate analysis
| |||||||
---|---|---|---|---|---|---|---|---|---|
Missing data
|
Emerging organisms
|
No emerging organisms
|
Odds ratio
|
95% CI
|
P
-value
|
Odds ratio
|
95% CI
|
P
-value
| |
(n = 115)
|
(n = 58)
| ||||||||
Time to reoperation, days | 0 | 6 ± 5 | 4 ± 3 | 1.19 | 1.07, 1.35 | 0.001 | 1.19 | 1.06, 1.36 | 0.004 |
Initial infection involving E. coli
| 0 | 52 (45) | 19 (33) | 1.69 | 0.88, 3.32 | 0.14 | - | - | - |
Initial infection involving Enterobacter spp. | 0 | 9 (8) | 9 (16) | 0.46 | 0.17, 1.25 | 0.18 | - | - | - |
Initial infection involving Candida | 0 | 45 (39) | 36 (62) | 0.39 | 0.20, 0.75 | 0.0059 | 0.40 | 0.20, 0.77 | 0.007 |
Use of third-generation cephalosporins | 0 | 7 (6) | 9 (16) | 0.35 | 0.12, 1.00 | 0.054 | - | - | - |
Use of glycopeptides | 0 | 27 (23) | 22 (38) | 0.50 | 0.25, 0.99 | 0.051 | - | - | - |
Use of fluoroquinolones | 0 | 13 (11) | 1 (2) | 7.26 | 1.39, 133.67 | 0.036 | - | - | - |
Inadequate anti-infective therapy | 0 | 12 (10) | 12 (21) | 0.44 | 0.18, 1.07 | 0.10 | - | - | - |
Risk factors for emergence of MDR bacteria
Variable
|
Univariate analysis
|
Multivariate analysis
| |||||||
---|---|---|---|---|---|---|---|---|---|
Missing data
|
Emerging MDR strains (n = 63)
|
No emergence of MDR strains (n = 110)
|
Odds ratio
|
95% CI
|
P
-value
|
Odds ratio
|
95% CI
|
P
-value
| |
Type 1 diabetes mellitus | 0 | 10 (16) | 7 (6) | 2.77 | 0.99, 7.08 | 0.061 | - | - | - |
SOFA score, per one point | 0 | 8 ± 4 | 7 ± 3 | 1.07 | 0.97, 1.17 | 0.17 | - | - | - |
Time to reoperation, days | 0 | 7 ± 6 | 4 ± 3 | 1.19 | 1.08, 1.32 | <0.0001 | 1.19 | 1.08-1.33 | 0.0006 |
Polymicrobial initial infection | 0 | 39 (62) | 86 (78) | 0.453 | 0.23, 0.89 | 0.034 | - | - | - |
Duration of anti-infective therapy, days | 0 | 8 ± 5 | 6 ± 4 | 1.12 | 1.04, 1.21 | 0.0003 | - | - | - |
Use of third-generation cephalosporins | 0 | 3 (5) | 13 (12) | 0.37 | 0.10, 1.36 | 0.17 | - | - | - |
Use of fluoroquinolones | 0 | 9 (14) | 5 (5) | 3.5 | 1.12, 10.95 | 0.039 | - | - | - |
Discussion
Conclusions
Key messages
-
Initial severity, presence of Candida and inadequate source control are the major risk factors leading to persistent abdominal sepsis during postoperative peritonitis
-
Emergence of multidrug resistant microorganisms occurs rapidly during persistent abdominal sepsis
-
The proportions of these multidrug-resistant microorganisms increase progressively with the number of reoperations for persistent abdominal sepsis